Capital Insight Partners, LLC Pfizer Inc Transaction History

Capital Insight Partners, LLC

$565 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$25.89 - $29.73 $66,796 - $76,703	-2,580 Reduced 2.89%	86,582 $2.4 Million
Q4 2023 Jan 24, 2024	BUY	$26.13 - $33.94 $23,595 - $30,647	903 Added 1.02%	89,162 $2.57 Million
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $82,663 - $96,625	2,576 Added 3.01%	88,259 $2.93 Million
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $1,480 - $1,713	-41 Reduced 0.05%	85,683 $3.14 Million
Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $144,009 - $187,479	3,656 Added 4.45%	85,724 $3.5 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $294,838 - $384,879	7,062 Added 9.42%	82,068 $4.21 Million
Q3 2022 Oct 20, 2022	BUY	$43.76 - $53.42 $46,341 - $56,571	1,059 Added 1.43%	75,006 $3.28 Million
Q2 2022 Jul 20, 2022	BUY	$46.53 - $55.17 $54,719 - $64,879	1,176 Added 1.62%	73,947 $3.88 Million
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $138,348 - $171,430	-3,024 Reduced 3.99%	72,771 $3.77 Million
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $17,767 - $26,337	430 Added 0.57%	75,795 $4.48 Million
Q3 2021 Oct 13, 2021	BUY	$39.25 - $50.42 $38,072 - $48,907	970 Added 1.3%	75,365 $3.24 Million
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $88,374 - $100,113	2,461 Added 3.42%	74,395 $2.91 Million
Q1 2021 Apr 20, 2021	BUY	$33.49 - $37.77 $682,593 - $769,828	20,382 Added 39.54%	71,934 $2.61 Million
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $14,124 - $17,960	422 Added 0.83%	51,552 $1.9 Million
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $13,589 - $15,943	428 Added 0.84%	51,130 $1.88 Million
Q2 2020 Jul 15, 2020	BUY	$30.12 - $36.54 $77,709 - $94,273	2,580 Added 5.36%	50,702 $1.66 Million
Q1 2020 Apr 14, 2020	BUY	$27.03 - $38.62 $76,359 - $109,101	2,825 Added 6.24%	48,122 $1.57 Million
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $18,929 - $21,482	-575 Reduced 1.25%	45,297 $1.78 Million
Q3 2019 Oct 09, 2019	BUY	$32.49 - $42.13 $2,436 - $3,159	75 Added 0.16%	45,872 $1.65 Million
Q2 2019 Jul 09, 2019	SELL	$36.98 - $41.52 $13,608 - $15,279	-368 Reduced 0.8%	45,797 $1.98 Million
Q1 2019 Apr 04, 2019	SELL	$37.5 - $41.2 $52,462 - $57,638	-1,399 Reduced 2.94%	46,165 $1.96 Million
Q4 2018 Jan 03, 2019	BUY	$38.47 - $43.86 $1,538 - $1,754	40 Added 0.08%	47,564 $2.08 Million
Q3 2018 Oct 04, 2018	SELL	$34.47 - $41.81 $1.75 Million - $2.13 Million	-50,893 Reduced 51.71%	47,524 $2.09 Million
Q2 2018 Jul 05, 2018	BUY	$32.98 - $35.16 $7,816 - $8,332	237 Added 0.24%	98,417 $3.57 Million
Q1 2018 Apr 16, 2018	BUY	$31.91 - $37.02 $62,639 - $72,670	1,963 Added 2.04%	98,180 $3.48 Million
Q4 2017 Jan 12, 2018	BUY	$33.26 - $35.29 $12,405 - $13,163	373 Added 0.39%	96,217 $3.49 Million
Q3 2017 Oct 10, 2017	BUY	$31.0 - $34.15 $2.97 Million - $3.27 Million	95,844	95,844 $3.42 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Insight Partners, LLC with notifications on news.

Account